Cargando…

Thrombocytopenia in adult patients with sepsis: incidence, risk factors, and its association with clinical outcome

BACKGROUND: Sepsis is a major risk factor for the development of thrombocytopenia, but few studies have specifically evaluated prognostic importance of thrombocytopenia in patients with sepsis. We investigated the incidence, risk factors, and prognostic importance of thrombocytopenia in adult patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Venkata, Chakradhar, Kashyap, Rahul, Farmer, J Christopher, Afessa, Bekele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4373028/
https://www.ncbi.nlm.nih.gov/pubmed/25810916
http://dx.doi.org/10.1186/2052-0492-1-9
_version_ 1782363278491516928
author Venkata, Chakradhar
Kashyap, Rahul
Farmer, J Christopher
Afessa, Bekele
author_facet Venkata, Chakradhar
Kashyap, Rahul
Farmer, J Christopher
Afessa, Bekele
author_sort Venkata, Chakradhar
collection PubMed
description BACKGROUND: Sepsis is a major risk factor for the development of thrombocytopenia, but few studies have specifically evaluated prognostic importance of thrombocytopenia in patients with sepsis. We investigated the incidence, risk factors, and prognostic importance of thrombocytopenia in adult patients admitted to the intensive care unit (ICU) with sepsis. METHODS: A retrospective analysis of patients admitted with severe sepsis/septic shock from December 2007 to January 2009 to a 24-bed medical ICU was done. RESULTS: A total of 304 patients were included in the study. The patients' mean (±SD) age was 68.8 (±15.8) years. The majority (93.7%) had septic shock, and pneumonia was the most common infection (38.8%). Thrombocytopenia developed in 145 patients (47.6%): 77 (25.3%) at ICU admission and 68 (22.3%) during their hospital course. The median (IQR) duration of thrombocytopenia was 4.4 (1.9–6.9) days. Patients who developed thrombocytopenia had more episodes of major bleeding (14.4% vs. 3.7%, P < 0.01) and received more transfusions. Patients with thrombocytopenia had a higher incidence of acute kidney injury (44.1% vs. 29.5%, P < 0.01), prolonged vasopressor support (median (IQR): 37 (17–76) vs. 23 (13–46) h, P < 0.01), and longer ICU stay (median (IQR): 3.1 (1.6–7.8) vs. 2.1 (1.2–4.4) days, P < 0.01). The 28-day mortality was similar between patients with and without thrombocytopenia (32.4% vs. 24.5%, P = 0.12). However, while 15 of 86 patients (17.4%) who resolved their thrombocytopenia died, 32 of 59 patients (54.2%) whose thrombocytopenia did not resolve died (P < 0.01). The association between non-resolution of thrombocytopenia and mortality remained significant after adjusting for age, APACHE III score and compliance with a sepsis resuscitation bundle (P < 0.01). CONCLUSIONS: Thrombocytopenia is common in patients who are admitted to the ICU with severe sepsis and septic shock. Patients with thrombocytopenia had more episodes of major bleeding, increased incidence of acute kidney injury, and prolonged ICU stay. Non-resolution of thrombocytopenia, but not thrombocytopenia itself, was associated with increased 28-day mortality.
format Online
Article
Text
id pubmed-4373028
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43730282015-03-26 Thrombocytopenia in adult patients with sepsis: incidence, risk factors, and its association with clinical outcome Venkata, Chakradhar Kashyap, Rahul Farmer, J Christopher Afessa, Bekele J Intensive Care Research BACKGROUND: Sepsis is a major risk factor for the development of thrombocytopenia, but few studies have specifically evaluated prognostic importance of thrombocytopenia in patients with sepsis. We investigated the incidence, risk factors, and prognostic importance of thrombocytopenia in adult patients admitted to the intensive care unit (ICU) with sepsis. METHODS: A retrospective analysis of patients admitted with severe sepsis/septic shock from December 2007 to January 2009 to a 24-bed medical ICU was done. RESULTS: A total of 304 patients were included in the study. The patients' mean (±SD) age was 68.8 (±15.8) years. The majority (93.7%) had septic shock, and pneumonia was the most common infection (38.8%). Thrombocytopenia developed in 145 patients (47.6%): 77 (25.3%) at ICU admission and 68 (22.3%) during their hospital course. The median (IQR) duration of thrombocytopenia was 4.4 (1.9–6.9) days. Patients who developed thrombocytopenia had more episodes of major bleeding (14.4% vs. 3.7%, P < 0.01) and received more transfusions. Patients with thrombocytopenia had a higher incidence of acute kidney injury (44.1% vs. 29.5%, P < 0.01), prolonged vasopressor support (median (IQR): 37 (17–76) vs. 23 (13–46) h, P < 0.01), and longer ICU stay (median (IQR): 3.1 (1.6–7.8) vs. 2.1 (1.2–4.4) days, P < 0.01). The 28-day mortality was similar between patients with and without thrombocytopenia (32.4% vs. 24.5%, P = 0.12). However, while 15 of 86 patients (17.4%) who resolved their thrombocytopenia died, 32 of 59 patients (54.2%) whose thrombocytopenia did not resolve died (P < 0.01). The association between non-resolution of thrombocytopenia and mortality remained significant after adjusting for age, APACHE III score and compliance with a sepsis resuscitation bundle (P < 0.01). CONCLUSIONS: Thrombocytopenia is common in patients who are admitted to the ICU with severe sepsis and septic shock. Patients with thrombocytopenia had more episodes of major bleeding, increased incidence of acute kidney injury, and prolonged ICU stay. Non-resolution of thrombocytopenia, but not thrombocytopenia itself, was associated with increased 28-day mortality. BioMed Central 2013-12-30 /pmc/articles/PMC4373028/ /pubmed/25810916 http://dx.doi.org/10.1186/2052-0492-1-9 Text en © Venkata et al.; licensee BioMed Central Ltd. 2013 This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Venkata, Chakradhar
Kashyap, Rahul
Farmer, J Christopher
Afessa, Bekele
Thrombocytopenia in adult patients with sepsis: incidence, risk factors, and its association with clinical outcome
title Thrombocytopenia in adult patients with sepsis: incidence, risk factors, and its association with clinical outcome
title_full Thrombocytopenia in adult patients with sepsis: incidence, risk factors, and its association with clinical outcome
title_fullStr Thrombocytopenia in adult patients with sepsis: incidence, risk factors, and its association with clinical outcome
title_full_unstemmed Thrombocytopenia in adult patients with sepsis: incidence, risk factors, and its association with clinical outcome
title_short Thrombocytopenia in adult patients with sepsis: incidence, risk factors, and its association with clinical outcome
title_sort thrombocytopenia in adult patients with sepsis: incidence, risk factors, and its association with clinical outcome
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4373028/
https://www.ncbi.nlm.nih.gov/pubmed/25810916
http://dx.doi.org/10.1186/2052-0492-1-9
work_keys_str_mv AT venkatachakradhar thrombocytopeniainadultpatientswithsepsisincidenceriskfactorsanditsassociationwithclinicaloutcome
AT kashyaprahul thrombocytopeniainadultpatientswithsepsisincidenceriskfactorsanditsassociationwithclinicaloutcome
AT farmerjchristopher thrombocytopeniainadultpatientswithsepsisincidenceriskfactorsanditsassociationwithclinicaloutcome
AT afessabekele thrombocytopeniainadultpatientswithsepsisincidenceriskfactorsanditsassociationwithclinicaloutcome